Literature DB >> 30100066

Optineurin E50K triggers BDNF deficiency-mediated mitochondrial dysfunction in retinal photoreceptor cell line.

Myoung Sup Shim1, Keun-Young Kim2, Mark Noh1, Ji Yoon Ko1, Sangphil Ahn1, Michelle A An1, Takeshi Iwata3, Guy A Perkins2, Robert N Weinreb1, Won-Kyu Ju4.   

Abstract

Optineurin (OPTN) mutations are linked to glaucoma pathology and E50K mutation shows massive cell death in photoreceptor cells and retinal ganglion cells. However, little is known about E50K-mediated mitochondrial dysfunction in photoreceptor cell degeneration. We here show that overexpression of E50K expression triggered BDNF deficiency, leading to Bax activation in RGC-5 cells. BDNF deficiency induced mitochondrial dysfunction by decreasing mitochondrial maximal respiration and reducing intracellular ATP level in RGC-5 cells. However, BDNF deficiency did not alter mitochondrial dynamics. Also, BDNF deficiency resulted in LC3-mediated mitophagosome formation in RGC-5 cells. These results strongly suggest that E50K-mediated BDNF deficiency plays a critical role in compromised mitochondrial function in glaucomatous photoreceptor cell degeneration.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; E50K mutation; Glaucoma; Mitochondrial dysfunction; Optineurin; RGC-5 cell

Mesh:

Substances:

Year:  2018        PMID: 30100066      PMCID: PMC6133749          DOI: 10.1016/j.bbrc.2018.08.025

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  49 in total

1.  Adult-onset primary open-angle glaucoma caused by mutations in optineurin.

Authors:  Tayebeh Rezaie; Anne Child; Roger Hitchings; Glen Brice; Lauri Miller; Miguel Coca-Prados; Elise Héon; Theodore Krupin; Robert Ritch; Donald Kreutzer; R Pitts Crick; Mansoor Sarfarazi
Journal:  Science       Date:  2002-02-08       Impact factor: 47.728

2.  Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy that is disrupted by an ALS-linked mutation.

Authors:  Yvette C Wong; Erika L F Holzbaur
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-07       Impact factor: 11.205

3.  Memantine blocks mitochondrial OPA1 and cytochrome c release and subsequent apoptotic cell death in glaucomatous retina.

Authors:  Won-Kyu Ju; Keun-Young Kim; Mila Angert; Karen X Duong-Polk; James D Lindsey; Mark H Ellisman; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-20       Impact factor: 4.799

4.  Optineurin negatively regulates TNFalpha- induced NF-kappaB activation by competing with NEMO for ubiquitinated RIP.

Authors:  Guozhi Zhu; Chuan-Jin Wu; Yongge Zhao; Jonathan D Ashwell
Journal:  Curr Biol       Date:  2007-08-21       Impact factor: 10.834

5.  Visual function deficits in glaucoma. Electroretinogram pattern and luminance nonlinearities.

Authors:  J V Odom; J G Feghali; J C Jin; G W Weinstein
Journal:  Arch Ophthalmol       Date:  1990-02

6.  Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease.

Authors:  C Zuccato; A Ciammola; D Rigamonti; B R Leavitt; D Goffredo; L Conti; M E MacDonald; R M Friedlander; V Silani; M R Hayden; T Timmusk; S Sipione; E Cattaneo
Journal:  Science       Date:  2001-06-14       Impact factor: 47.728

7.  Measurement of photoreceptor layer in glaucoma: a spectral-domain optical coherence tomography study.

Authors:  Ning Fan; Nina Huang; Dennis Shun Chiu Lam; Christopher Kai-Shun Leung
Journal:  J Ophthalmol       Date:  2011-08-10       Impact factor: 1.909

8.  Increased mitochondrial fission and volume density by blocking glutamate excitotoxicity protect glaucomatous optic nerve head astrocytes.

Authors:  Won-Kyu Ju; Keun-Young Kim; You Hyun Noh; Masahiko Hoshijima; Thomas J Lukas; Mark H Ellisman; Robert N Weinreb; Guy A Perkins
Journal:  Glia       Date:  2014-12-31       Impact factor: 7.452

9.  661W is a retinal ganglion precursor-like cell line in which glaucoma-associated optineurin mutants induce cell death selectively.

Authors:  Zuberwasim Sayyad; Kapil Sirohi; Vegesna Radha; Ghanshyam Swarup
Journal:  Sci Rep       Date:  2017-12-04       Impact factor: 4.379

10.  Inhibition of oxidative stress by coenzyme Q10 increases mitochondrial mass and improves bioenergetic function in optic nerve head astrocytes.

Authors:  Y H Noh; K-Y Kim; M S Shim; S-H Choi; S Choi; M H Ellisman; R N Weinreb; G A Perkins; W-K Ju
Journal:  Cell Death Dis       Date:  2013-10-03       Impact factor: 8.469

View more
  5 in total

Review 1.  Emerging views of OPTN (optineurin) function in the autophagic process associated with disease.

Authors:  Yueping Qiu; Jincheng Wang; Hui Li; Bo Yang; Jiajia Wang; Qiaojun He; Qinjie Weng
Journal:  Autophagy       Date:  2021-04-13       Impact factor: 16.016

2.  Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization.

Authors:  Won-Kyu Ju; Myoung Sup Shim; Keun-Young Kim; Tae Lim Park; Sangphil Ahn; Genea Edwards; Robert N Weinreb
Journal:  Oxid Med Cell Longev       Date:  2019-11-06       Impact factor: 6.543

3.  The E50K optineurin mutation impacts autophagy-mediated degradation of TDP-43 and leads to RGC apoptosis in vivo and in vitro.

Authors:  Shiqi Zhang; Zhengbo Shao; Xinna Liu; Mingying Hou; Fang Cheng; Dawei Lei; Huiping Yuan
Journal:  Cell Death Discov       Date:  2021-03-15

4.  Systemic Beta-Hydroxybutyrate Affects BDNF and Autophagy into the Retina of Diabetic Mice.

Authors:  Maria Consiglia Trotta; Carlo Gesualdo; Hildegard Herman; Sami Gharbia; Cornel Balta; Caterina Claudia Lepre; Marina Russo; Annalisa Itro; Giovanbattista D'Amico; Luisa Peluso; Iacopo Panarese; Gorizio Pieretti; Giuseppe Ferraro; Francesca Simonelli; Michele D'Amico; Settimio Rossi; Anca Hermenean
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

Review 5.  Is Brain-Derived Neurotrophic Factor a Metabolic Hormone in Peripheral Tissues?

Authors:  Elsie Chit Yu Iu; Chi Bun Chan
Journal:  Biology (Basel)       Date:  2022-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.